HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Vascular Biogenics (NASDAQ:VBLT) from Buy to Neutral.
4 Analysts Have This To Say About Moelis
4 analysts have expressed a variety of opinions on Moelis (NYSE:MC) over the past quarter, offering a diverse…